Sfoglia per Autore
Consolidation with Bortezomib, Thalidomide and Dexamethasone Induces Molecular Remissions in Autografted Multiple Myeloma Patients
2007-01-01 Marco Ladetto; Gloria Pagliano; Ilaria Avonto; Loredana Santo; Simone Ferrero; Federica Cavallo; Monica Astolfi; Patrizia Pregno; Claudia Crippa; Anna Marina Liberati; Vincenzo Callea; Luca De Rosa; Antonietta Falcone; Mariella Grasso; Daniela Drandi; Mario Boccadoro; Antonio Palumbo
Major Shrinking of Residual Tumor Cell Burden and Achievement of Molecular Remissions in Myeloma Patients Undergoing Post-Trasplant Consolidation with Bortezomib, Thalidomide and Dexamethasone: A Qualitative and Quantitative PCR Study
2008-01-01 Marco Ladetto; Gloria Pagliano; Simone Ferrero; Federica Cavallo; Daniela Drandi; Michela Boi; Loredana Santo; Patrizia Pregno; Mariella Grasso; Anna Marina Liberati; Tommaso Caravita; Francesco Pisani; Claudia Crippa; Vincenzo Callea; Antonietta Falcone; Sergio Morandi; Mario Boccadoro; Antonio Palumbo
Telomere Length Is An Independent Predictor of Survival, Treatment Requirement and Richter’s Syndrome Transformation in Chronic Lymphocytic Leukemia
2008-01-01 Davide Rossi; Chiara Lobetti Bodoni; Elisa Genuardi; Luigia Monitillo; Daniela Drandi; Clara Deambrogi; Michaela Cerri; Irene Ricca; Alberto Rocci; Simone Ferrero; Elisa Bernocco; Daniela Capello; Lorenzo De Paoli; Luciana Bergui; Michela Boi; Paola Omedè; Massimo Massaia; Corrado Tarella; Roberto Passera; Mario Boccadoro; Gianluca Gaidano; Marco Ladetto
Correlation Between Clinical Outcome and Disease Kinetics by Quantitative PCR in Myeloma Patients Following Post-Transplant Consolidation with Bortezomib, Thalidomide and Dexamethasone
2009-01-01 Marco Ladetto; Gloria Pagliano; Simone Ferrero; Federica Cavallo; Daniela Drandi; Michela Boi; Loredana Santo; Claudia Crippa; Luca De Rosa; Patrizia Pregno; Mariella Grasso; Anna Marina Liberati; Tommaso Caravita; Francesco Pisani; Tommasina Guglielmelli; Vincenzo Callea; Fausto Rossini; Pellegrino Musto; Clotilde Cangialosi; Alberto Rocci; Roberto Passera; Mario Boccadoro; Antonio Palumbo
Telomere length is an independent predictor of survival, treatment requirement and Richter’s syndrome transformation in chronic lymphocytic leukemia
2009-01-01 D Rossi;C Lobetti Bodoni;E Genuardi;L Monitillo;D Drandi;M Cerri;C Deambrogi;I Ricca;A Rocci;S Ferrero;E Bernocco;D Capello;L De Paoli;L Bergui;M Boi;P Omedè;M Massaia;C Tarella;R Passera;M Boccadoro;G Gaidano;M Ladetto
Characteristics of the Immunoglobulin Heavy Chain (IgH) Rearrangement in Multiple Myeloma (MM): An Analysis On 308 Cases
2009-01-01 Simone Ferrero; Daniela Capello; Mirija Svaldi; Michela Boi; Daniela Drandi; Davide Rossi; Gloria Pagliano; Luigia Monitillo; Chiara Lobetti Bodoni; Elisa Genuardi; Rossana Critelli; Serena Bussano; Daniela Barbero; Barbara Mantoan; Elisa Bernocco; Antonio Palumbo; Mario Boccadoro; Gianluca Gaidano; Sergio Cortelazzo; Marco Ladetto
Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia
2009-01-01 D Rossi;C Lobetti Bodoni;E Genuardi;L Monitillo;D Drandi;M Cerri;C Deambrogi;I Ricca;A Rocci;S Ferrero;E Bernocco;D Capello;L De Paoli;L Bergui;M Boi;P Omedè;M Massaia;C Tarella;R Passera;M Boccadoro;G Gaidano;M Ladetto
Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma
2010-01-01 Ladetto M; Pagliano G; Ferrero S; Cavallo F; Drandi D; Santo L; Crippa C; De Rosa L; Pregno P; Grasso M; Liberati AM; Caravita T; Pisani F; Guglielmelli T; Callea V; Musto P; Cangialosi C; Passera R; Boccadoro M; Palumbo A.
Expression of telomeric proteins in chronic lymphocytic leukemia (CLL)
2011-01-01 Barbero D; Drandi D; Lobetti Bodoni C; Bernocco E; Coscia M; Ruggeri M; Boi M; Genuardi E; Monitillo L; Mantoan B; Maffeo C; Barbiero S; Ferrero S; Rossi D; Passera R; Gaidano G; Massaia M; Omedè P; Boccadoro M; Ladetto M
Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells
2011-01-01 Lamorte S; Ferrero S; Aschero S; Monitillo L; Bussolati B; Omedè P; Ladetto M; Camussi G.
LONG-TERM RESULTS of the GIMEMA VTD Consolidation TRIAL In Autografted MULTIPLE Myeloma PATIENTS (VEL-03-096): IMPACT of Minimal RESIDUAL DISEASE Detection by REAL Time Quantitative PCR On LATE Recurrences and Overall SURVIVAL
2011-01-01 Ladetto M.; Ferrero S.; Drandi D.; Cavallo F.; Monitillo L.; et al.
Minimal residual disease detection in lymphoma and multiple myeloma: impact on therapeutic paradigms
2011-01-01 Simone Ferrero;Daniela Drandi;Barbara Mantoan;Paola Ghione;Paola Omedè;Marco Ladetto
SYNDECAN-1 PROMOTES THE ANGIOGENIC PHENOTYPE OF MULTIPLE MYELOMA ENDOTHELIAL CELLS
2012-01-01 Lamorte, S.; Ferrero, S.; Aschero, S.; Monitillo L,
High Rates of Prolonged Molecular Remissions After Tandem Autologous-Nonmyeloablative Allografting in Newly Diagnosed Myeloma
2012-01-01 Marco Ladetto; Simone Ferrero; Daniela Drandi; Paola Omedè; Francesca Patriarca; Nicola Mordini; Silvia Cena; Daniela Barbero; Luigia Monitillo; Luisa Giaccone; Alberto Rocci; Sara Barbiero; Moreno Festuccia; Andrea Gallamini; Renato Fanin; Roberto Passera; Antonio Palumbo; Mario Boccadoro; Benedetto Bruno
Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP.
2012-01-01 Pregno P;Chiappella A;Bellò M;Botto B;Ferrero S;Franceschetti S;Giunta F;Ladetto M;Limerutti G;Menga M;Nicolosi M;Priolo G;Puccini B;Rigacci L;Salvi F;Vaggelli L;Passera R;Bisi G;Vitolo U
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes
2012-01-01 Ferrero S; Capello D; Svaldi M; Boi M; Gatti D; Drandi D; Rossi D; Barbiero S; Mantoan B; Mantella E; Zanni M; Ghione P; Larocca A; Passera R; Bertoni F; Gattei V; Forconi F; Laurenti L; Del Poeta G; Marasca R; Cortelazzo S; Gaidano G; Palumbo A; Boccadoro M; Ladetto M.
High Rates of Prolonged Molecular Remissions After Tandem Autologous-Nonmyeloablative Allografting in Newly Diagnosed Myeloma
2013-01-01 Benedetto Bruno; Simone Ferrero; Daniela Drandi; Moreno Festuccia; Francesca Patriarca; Nicola Mordini; Silvia Cena; Daniela Barbero; Luigia Monitillo; Luisa Giaccone; Sara Barbiero; Andrea Gallamini3; Renato Fanin; Roberto Passera; Antonio Palumbo; Mario Boccadoro; Paola Omedè and Marco Ladetto
High Rates of Prolonged Molecular Remissions After Tandem Autologous-Nonmyeloablative Allografting in Newly Diagnosed Myeloma
2013-01-01 Benedetto Bruno; Simone Ferrero; Daniela Drandi ; Moreno Festuccia; Francesca Patriarca; Nicola Mordini; Silvia Cena; Luigia Monitillo; Luisa Giaccone; Federica Ferrando; Daniela Barbero; Alberto Rocci; Sara Barbiero; Andrea Gallamini; Renato Fanin; Roberto Passera; Antonio Palumbo; Mario Boccadoro; Paola Omedè; Marco Ladetto
HIGH RATES OF PROLONGED MOLECULAR REMISSIONS AFTER TANDEM AUTOLOGOUS-NONMYELOABLATIVE ALLOGRAFTING IN NEWLY DIAGNOSED MYELOMA
2013-01-01 Ladetto M, Ferrero S, Drandi D,; Festuccia M.; Patriarca F.; Mordini N.; Cena S.; Barbero D.; Monitillo L.
The current therapeutic scenario for relapsed mantle cell lymphoma
2013-01-01 Simone Ferrero; Martin Dreyling
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Consolidation with Bortezomib, Thalidomide and Dexamethasone Induces Molecular Remissions in Autografted Multiple Myeloma Patients | 2007 | Marco Ladetto; Gloria Pagliano; Ilaria Avonto; Loredana Santo; Simone Ferrero; Federica Cavallo; Monica Astolfi; Patrizia Pregno; Claudia Crippa; Anna Marina Liberati; Vincenzo Callea; Luca De Rosa; Antonietta Falcone; Mariella Grasso; Daniela Drandi; Mario Boccadoro; Antonio Palumbo | |
| Major Shrinking of Residual Tumor Cell Burden and Achievement of Molecular Remissions in Myeloma Patients Undergoing Post-Trasplant Consolidation with Bortezomib, Thalidomide and Dexamethasone: A Qualitative and Quantitative PCR Study | 2008 | Marco Ladetto; Gloria Pagliano; Simone Ferrero; Federica Cavallo; Daniela Drandi; Michela Boi; Loredana Santo; Patrizia Pregno; Mariella Grasso; Anna Marina Liberati; Tommaso Caravita; Francesco Pisani; Claudia Crippa; Vincenzo Callea; Antonietta Falcone; Sergio Morandi; Mario Boccadoro; Antonio Palumbo | |
| Telomere Length Is An Independent Predictor of Survival, Treatment Requirement and Richter’s Syndrome Transformation in Chronic Lymphocytic Leukemia | 2008 | Davide Rossi; Chiara Lobetti Bodoni; Elisa Genuardi; Luigia Monitillo; Daniela Drandi; Clara Deambrogi; Michaela Cerri; Irene Ricca; Alberto Rocci; Simone Ferrero; Elisa Bernocco; Daniela Capello; Lorenzo De Paoli; Luciana Bergui; Michela Boi; Paola Omedè; Massimo Massaia; Corrado Tarella; Roberto Passera; Mario Boccadoro; Gianluca Gaidano; Marco Ladetto | |
| Correlation Between Clinical Outcome and Disease Kinetics by Quantitative PCR in Myeloma Patients Following Post-Transplant Consolidation with Bortezomib, Thalidomide and Dexamethasone | 2009 | Marco Ladetto; Gloria Pagliano; Simone Ferrero; Federica Cavallo; Daniela Drandi; Michela Boi; Loredana Santo; Claudia Crippa; Luca De Rosa; Patrizia Pregno; Mariella Grasso; Anna Marina Liberati; Tommaso Caravita; Francesco Pisani; Tommasina Guglielmelli; Vincenzo Callea; Fausto Rossini; Pellegrino Musto; Clotilde Cangialosi; Alberto Rocci; Roberto Passera; Mario Boccadoro; Antonio Palumbo | |
| Telomere length is an independent predictor of survival, treatment requirement and Richter’s syndrome transformation in chronic lymphocytic leukemia | 2009 | D Rossi;C Lobetti Bodoni;E Genuardi;L Monitillo;D Drandi;M Cerri;C Deambrogi;I Ricca;A Rocci;S Ferrero;E Bernocco;D Capello;L De Paoli;L Bergui;M Boi;P Omedè;M Massaia;C Tarella;R Passera;M Boccadoro;G Gaidano;M Ladetto | |
| Characteristics of the Immunoglobulin Heavy Chain (IgH) Rearrangement in Multiple Myeloma (MM): An Analysis On 308 Cases | 2009 | Simone Ferrero; Daniela Capello; Mirija Svaldi; Michela Boi; Daniela Drandi; Davide Rossi; Gloria Pagliano; Luigia Monitillo; Chiara Lobetti Bodoni; Elisa Genuardi; Rossana Critelli; Serena Bussano; Daniela Barbero; Barbara Mantoan; Elisa Bernocco; Antonio Palumbo; Mario Boccadoro; Gianluca Gaidano; Sergio Cortelazzo; Marco Ladetto | |
| Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia | 2009 | D Rossi;C Lobetti Bodoni;E Genuardi;L Monitillo;D Drandi;M Cerri;C Deambrogi;I Ricca;A Rocci;S Ferrero;E Bernocco;D Capello;L De Paoli;L Bergui;M Boi;P Omedè;M Massaia;C Tarella;R Passera;M Boccadoro;G Gaidano;M Ladetto | |
| Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma | 2010 | Ladetto M; Pagliano G; Ferrero S; Cavallo F; Drandi D; Santo L; Crippa C; De Rosa L; Pregno P; Grasso M; Liberati AM; Caravita T; Pisani F; Guglielmelli T; Callea V; Musto P; Cangialosi C; Passera R; Boccadoro M; Palumbo A. | |
| Expression of telomeric proteins in chronic lymphocytic leukemia (CLL) | 2011 | Barbero D; Drandi D; Lobetti Bodoni C; Bernocco E; Coscia M; Ruggeri M; Boi M; Genuardi E; Monitillo L; Mantoan B; Maffeo C; Barbiero S; Ferrero S; Rossi D; Passera R; Gaidano G; Massaia M; Omedè P; Boccadoro M; Ladetto M | |
| Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells | 2011 | Lamorte S; Ferrero S; Aschero S; Monitillo L; Bussolati B; Omedè P; Ladetto M; Camussi G. | |
| LONG-TERM RESULTS of the GIMEMA VTD Consolidation TRIAL In Autografted MULTIPLE Myeloma PATIENTS (VEL-03-096): IMPACT of Minimal RESIDUAL DISEASE Detection by REAL Time Quantitative PCR On LATE Recurrences and Overall SURVIVAL | 2011 | Ladetto M.; Ferrero S.; Drandi D.; Cavallo F.; Monitillo L.; et al. | |
| Minimal residual disease detection in lymphoma and multiple myeloma: impact on therapeutic paradigms | 2011 | Simone Ferrero;Daniela Drandi;Barbara Mantoan;Paola Ghione;Paola Omedè;Marco Ladetto | |
| SYNDECAN-1 PROMOTES THE ANGIOGENIC PHENOTYPE OF MULTIPLE MYELOMA ENDOTHELIAL CELLS | 2012 | Lamorte, S.; Ferrero, S.; Aschero, S.; Monitillo L, | |
| High Rates of Prolonged Molecular Remissions After Tandem Autologous-Nonmyeloablative Allografting in Newly Diagnosed Myeloma | 2012 | Marco Ladetto; Simone Ferrero; Daniela Drandi; Paola Omedè; Francesca Patriarca; Nicola Mordini; Silvia Cena; Daniela Barbero; Luigia Monitillo; Luisa Giaccone; Alberto Rocci; Sara Barbiero; Moreno Festuccia; Andrea Gallamini; Renato Fanin; Roberto Passera; Antonio Palumbo; Mario Boccadoro; Benedetto Bruno | |
| Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP. | 2012 | Pregno P;Chiappella A;Bellò M;Botto B;Ferrero S;Franceschetti S;Giunta F;Ladetto M;Limerutti G;Menga M;Nicolosi M;Priolo G;Puccini B;Rigacci L;Salvi F;Vaggelli L;Passera R;Bisi G;Vitolo U | |
| Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes | 2012 | Ferrero S; Capello D; Svaldi M; Boi M; Gatti D; Drandi D; Rossi D; Barbiero S; Mantoan B; Mantella E; Zanni M; Ghione P; Larocca A; Passera R; Bertoni F; Gattei V; Forconi F; Laurenti L; Del Poeta G; Marasca R; Cortelazzo S; Gaidano G; Palumbo A; Boccadoro M; Ladetto M. | |
| High Rates of Prolonged Molecular Remissions After Tandem Autologous-Nonmyeloablative Allografting in Newly Diagnosed Myeloma | 2013 | Benedetto Bruno; Simone Ferrero; Daniela Drandi; Moreno Festuccia; Francesca Patriarca; Nicola Mordini; Silvia Cena; Daniela Barbero; Luigia Monitillo; Luisa Giaccone; Sara Barbiero; Andrea Gallamini3; Renato Fanin; Roberto Passera; Antonio Palumbo; Mario Boccadoro; Paola Omedè and Marco Ladetto | |
| High Rates of Prolonged Molecular Remissions After Tandem Autologous-Nonmyeloablative Allografting in Newly Diagnosed Myeloma | 2013 | Benedetto Bruno; Simone Ferrero; Daniela Drandi ; Moreno Festuccia; Francesca Patriarca; Nicola Mordini; Silvia Cena; Luigia Monitillo; Luisa Giaccone; Federica Ferrando; Daniela Barbero; Alberto Rocci; Sara Barbiero; Andrea Gallamini; Renato Fanin; Roberto Passera; Antonio Palumbo; Mario Boccadoro; Paola Omedè; Marco Ladetto | |
| HIGH RATES OF PROLONGED MOLECULAR REMISSIONS AFTER TANDEM AUTOLOGOUS-NONMYELOABLATIVE ALLOGRAFTING IN NEWLY DIAGNOSED MYELOMA | 2013 | Ladetto M, Ferrero S, Drandi D,; Festuccia M.; Patriarca F.; Mordini N.; Cena S.; Barbero D.; Monitillo L. | |
| The current therapeutic scenario for relapsed mantle cell lymphoma | 2013 | Simone Ferrero; Martin Dreyling |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile